Literature DB >> 1979422

Antioxidant and glutathione-related enzymatic activities in rat sciatic nerve.

F J Romero1, J Segura-Aguilar, E Monsalve, C Hermenegildo, E Nies, F J Puertas, J Romá.   

Abstract

The present work tries to establish the antioxidant capacity of the peripheral nervous tissue of the rat, in terms of the enzymatic activities present in this tissue that either prevent the formation of activated species as the semiquinone radical (DT-diaphorase), protect against activated oxygen species (superoxide dismutase, glutathione peroxidase), conjugate natural toxic products or xenobiotics (glutathione S-transferase, especially the activity conjugating 4-hydroxy-nonenal), or complete the glutathione system metabolism (glutathione disulfide reductase, gamma-glutamyl transpeptidase). All the activities studied are lower in this tissue than they are in liver, except for gamma-glutamyl transpeptidase. The relevance of the results obtained and its possible relationship with different neuropathies is discussed. It is concluded that the peripheral nervous tissue is by far less protected than the liver against oxidative damage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979422     DOI: 10.1016/0892-0362(90)90069-o

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  5 in total

1.  Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine.

Authors:  M Sagara; J Satoh; R Wada; S Yagihashi; K Takahashi; M Fukuzawa; G Muto; Y Muto; T Toyota
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

2.  Comparison of metabolic and neuropathy profiles of rats with streptozotocin-induced overt and moderate insulinopenia.

Authors:  D Romanovsky; J Wang; E D Al-Chaer; J R Stimers; M Dobretsov
Journal:  Neuroscience       Date:  2010-07-01       Impact factor: 3.590

3.  The heme precursor delta-aminolevulinate blocks peripheral myelin formation.

Authors:  Natalia Felitsyn; Colin McLeod; Albert L Shroads; Peter W Stacpoole; Lucia Notterpek
Journal:  J Neurochem       Date:  2008-07-04       Impact factor: 5.372

4.  Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat.

Authors:  B Bravenboer; A C Kappelle; F P Hamers; T van Buren; D W Erkelens; W H Gispen
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

Review 5.  The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects.

Authors:  G A Hospers; E A Eisenhauer; E G de Vries
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.